Lung function development in the first 2 yr of life is independent of allergic diseases by 2 yr

Geir Håland1, Kai-Håkon Carlsen, Chandra Sekhar Devulapalli

  • 1Department of Pediatrics, Division of Woman and Child, Ullevål University Hospital, Oslo, Norway. geir.haland@medisin.uio.no

Insights

Infant lung function at birth predicts lung function at two years. However, common childhood conditions like recurrent bronchial obstruction or atopic eczema do not influence this lung function development trajectory.

Area of Science:

  • Pediatric Pulmonology
  • Respiratory Physiology
  • Childhood Asthma Research

Background:

  • Lung function assessment in infancy is crucial for understanding respiratory health trajectories.
  • Recurrent bronchial obstruction (rBO) and atopic eczema (AE) are common childhood conditions that may impact lung development.
  • Predictive markers for lung function in early childhood are essential for early intervention strategies.

Purpose of the Study:

  • To determine if infant lung function predicts lung function at two years of age.
  • To investigate the influence of recurrent bronchial obstruction (rBO) and atopic eczema (AE) phenotypes on lung function development by age two.
  • To analyze the tracking of lung function parameters from birth to early childhood.

Main Methods:

  • Prospective birth cohort study ('Environment and Childhood Asthma Study' in Oslo) with lung function measurements at birth (n=802) and 2 years (n=90).
  • Lung function assessed using tidal flow volume (TFV) loops and passive respiratory mechanics, focusing on time to peak tidal expiratory flow/total expiratory time (t(PTEF)/t(E)).
  • Children categorized by quartiles of t(PTEF)/t(E) at birth and by clinical phenotype (rBO and/or AE) at 2 years.

Main Results:

  • A significant correlation was observed between t(PTEF)/t(E) at birth and at 2 years (r=0.475, p<0.001), indicating lung function tracking.
  • Children with both rBO and AE by 2 years showed significantly lower t(PTEF)/t(E) at both birth (p=0.027) and 2 years (p=0.002) compared to children without these conditions.
  • Clinical phenotype (rBO/AE) did not significantly influence the change in t(PTEF)/t(E) from birth to 2 years after controlling for regression to the mean.

Conclusions:

  • Infant lung function demonstrates significant tracking into early childhood.
  • The development of lung function from birth to 2 years is not significantly influenced by the presence of recurrent bronchial obstruction or atopic eczema.
  • Early lung function measurements can serve as a predictor for respiratory health in the first two years of life.

Related Concept Videos

Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
Gross Anatomy of the Lungs01:17

Gross Anatomy of the Lungs

The lungs are a pair of vital organs connected to the trachea via the left and right bronchi. The base of these organs meets the dome-shaped muscle known as the diaphragm. Encased by the pleurae, the lungs contact the mediastinum. The right lung is shorter yet wider, and has a larger volume than the left lung. The left lung has an indentation known as the cardiac notch. The superior region of the lungs is referred to as the apex, whereas the base is the lower region near the diaphragm. The...
Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Breathing01:05

Breathing

The process of breathing, inhaling and exhaling, involves the coordinated movement of the chest wall, the lungs, and the muscles that move them. Two muscle groups with important roles in breathing are the diaphragm, located directly below the lungs, and the intercostal muscles, which lie between the ribs. When the diaphragm contracts, it moves downward, increasing the volume of the thoracic cavity and creating more room for the lungs to expand. When the intercostal muscles contract, the ribs...
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...